Graphenea is a private European company (based in Spain) focused on the production of high quality graphene for industrial applications. Graphenea produces both CVD graphene (using Aixtron’s Black Magic equipment) and Graphene Oxide materials.
The company offers graphene on several substrates and can also transfer the graphene to your own substrate in-house.
In 2020 Graphenea launched a dedicated Graphene Foundry. The company can take care of CVD graphene synthesis, transfer and device fabrication and deliver a fully tested graphene-based chip to the customer. This service reduces product development time and costs and Graphenea offers a reliable supply of graphene-based chips from prototyping to scale production.
In 2021, Graphenea updated us that its CVD graphene revenue in 2020 was 1.56 million Euro. The company expects to continue and grow at a CAGR of around 30% in the near future. Its current yearly production capacity is 8,760 200 mm wafers, but the company plans to increase that 25-fold in coming years.
Graphenea’s main CVD graphene applications are in Biosensors, Photosensors and Photonics.
The latest graphene news from Graphenea:
The International Graphene Awards (IGA) was initiated by the Chinese Graphene Industry Association (CGIA) in collaboration with 50 graphene experts from all over the world.
In 2020 the IGA committee offered 5 different awards: for best graphene products, best graphene firm, industry promotion, industry demonstration and honorary award for the most contribution people in graphene industry.
Graphenea recently announced that its graphene foundry service (GFAB), launched in 2019, will be getting an upgrade. Graphenea Foundry said that it will start a Multi-Project Wafer run service from January 2021, and it is currently speaking with customers interested in this first run.
Graphenea Foundry follows a pure-play foundry model, in which it manufactures graphene-based devices for its customers and third parties under request. Nevertheless, the factory also makes usable plug&play graphene devices from scratch, thus covering all aspects of device manufacturing. The staple product and the starting point for satisfying most customer needs is the GFET, the graphene field effect transistor. These readily-available devices are said to be ideal for early experiments and proof-of-concept measurements.
Graphenea has announced the successful completion of project G4SEMI, funded by the European Commission SME Instrument.
The project, which lasted two years, aimed at integrating graphene into CMOS semiconductor workflows. The business goal was to create added value through fast-tracking market acceptance of graphene-on-wafer by lowering the technological barriers to adoption of graphene by the €545 billion semiconductor devices industry.
As researchers and companies all over the world set out to battle the Coronavirus pandemic, many are revisiting graphene as a material with potential for helping to win this fight. The reasons for such potential could be found in graphene's known antibacterial/antiviral properties, its beneficial traits for medical sensors and devices and more.
Graphene has been shown in the past as extremely useful for creating various sensors. Earlier this month, a team led by Boston College researchers used a sheet of graphene to track the electronic signals inherent in biological structures, in order to develop a platform to selectively identify deadly strains of bacteria. In October 2019, Rice University team under chemist James Tour transformed their laser-induced graphene (LIG) into self-sterilizing filters that grab pathogens out of the air and kill them with small pulses of electricity. Commercially sold graphene-based sensors exist, like the graphene oxide (GO) sensor developed by the ICN2 Nanobioelectronics and Biosensors group that was added in 2016 to the list products offered by Biolin Scientific, a prestigious instrumentation company devoted to the production of analytical devices. The Q-Sense GO sensor enables interaction studies of GO with various analytes (measured substances) of interest and may open the door to various applications with interest for diagnostics, safety/security and environmental monitoring.
With the emergence of the Covid-19 virus and its global threat, Graphenea initiated several steps to try and help those trying to combat this crisis. On March 16th, Graphenea approached all those performing research on treatment and diagnosis of Covid-19, to offer free graphene.
Now, Graphenea announced the production of a disinfectant alcohol-based hydrogel following World Health Organization recommendations and pharmaceutical guidelines. As part of its effort to join the battle against COVID-19, Graphenea will donate the hand sanitizer to public authorities for use in hospitals, by seniors, police and/or military personnel. The aim is to protect medical personnel, high risk groups, and law enforcement agents against the virus.